SI-BONE websites use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and how to manage them, see our cookie policy.
The iFuse Implant, first cleared by the FDA in 2009, is the only device for treatment of SI joint dysfunction that is supported by significant published clinical evidence, including two level 1 randomized controlled trials (RCTs).
